{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:59:53Z","timestamp":1791291593928,"version":"4.3.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Saudi Cancer Registry reported in 2007 the 5-year observed survival for the most common cancer sites for the years 1994\u20132004. In this report we looked at the cancer survival in the period 2005\u20132009 and evaluated the trend over the 15\u00a0years period from 1994 to 2009. Cases of the top 14 cancer sites reported by the population based Saudi Cancer Registry from 1 January 2005 to December 31, 2009, were submitted for survival analysis. The vital status of those patients was collected. Analysis of survival for the above period was compared with the prior reported 2 periods (1994\u20131999, 2000\u20132004). In addition, analysis was done according to age, sex, disease stage and the province. Data of 25,969 patients of the commonest cancer sites were submitted. Of those 14,146 patients (54%) had complete demographic data available and vital status was reported. Thyroid cancer had the highest 5- year observed survival of 94% (95% confidence interval (CI) 93\u201395%)), followed by Breast (72%, 95% CI 71\u201374%). In hematological malignancies, Hodgkin\u2019s Lymphoma had the highest 5-year survival of 86% (95% CI 84\u201388%). Survival rates has improved in most of the cancers sites for the studied periods except for lung, uterine and Hodgkin\u2019s lymphoma which plateaued. Our study confirms a steady improvement in the 5-year observed survival over time for the majority of cancers. Our survival data were comparable to western countries. This data should be used by policy makers to improve on cancer care in the kingdom.<\/jats:p>","DOI":"10.1038\/s41598-021-04374-6","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T11:03:21Z","timestamp":1641553401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Population-based survival for cancer patients in Saudi Arabia for the years 2005\u20132009"],"prefix":"10.1038","volume":"12","author":[{"given":"Mohamed","family":"Aseafan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Devol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"AlAhwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Souissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Sindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya","family":"AlEid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8913-8158","authenticated-orcid":false,"given":"Shouki","family":"Bazarbashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"key":"4374_CR1","unstructured":"Cancer Incidence in Five Continents, ed. F.B. D. Forman, D.H. Brewster, C. Gombe Mbalawa, B. Kohler, M. Pi\u00f1eros, E. Steliarova-Foucher, R. Swaminathan and J. Ferlay Vol. Volume X. 2014, Lyon, France: The International Agency for Reseach on Cancer. 1365."},{"key":"4374_CR2","unstructured":"National Health Information Center. Cancer Incidence Report, Saudi Arabia, 2009 [cited 2021 31 January 2021]; Available from: https:\/\/nhic.gov.sa\/en\/eServices\/Pages\/TumorRegistration.aspx."},{"issue":"9","key":"4374_CR3","first-page":"2437","volume":"18","author":"S Bazarbashi","year":"2017","unstructured":"Bazarbashi, S., Al Eid, H. & Minguet, J. Cancer Incidence in Saudi Arabia: 2012 Data from the Saudi Cancer Registry. Asian Pac. J. Cancer Prev. 18(9), 2437\u20132444 (2017).","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"4374_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12094-017-1710-6","volume":"20","author":"MD Chirlaque","year":"2018","unstructured":"Chirlaque, M. D. et al. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries. Clin. Transl. Oncol. 20(2), 201\u2013211 (2018).","journal-title":"Clin. Transl. Oncol."},{"issue":"9972","key":"4374_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","volume":"385","author":"C Allemani","year":"2015","unstructured":"Allemani, C. et al. Global surveillance of cancer survival 1995\u20132009: Analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972), 977\u20131010 (2015).","journal-title":"Lancet"},{"issue":"3","key":"4374_CR6","doi-asserted-by":"publisher","first-page":"e0119051","DOI":"10.1371\/journal.pone.0119051","volume":"10","author":"C El Bcheraoui","year":"2015","unstructured":"El Bcheraoui, C. et al. Breast cancer screening in Saudi Arabia: free but almost no takers. PLoS ONE 10(3), e0119051 (2015).","journal-title":"PLoS ONE"},{"issue":"2","key":"4374_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.26719\/2015.21.2.111","volume":"21","author":"FA Al Mulhim","year":"2015","unstructured":"Al Mulhim, F. A. et al. Breast cancer screening programme: experience from Eastern province, Saudi Arabia. East Mediterr. Health J. 21(2), 111\u2013119 (2015).","journal-title":"East Mediterr. Health J."},{"issue":"5","key":"4374_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4103\/0256-4947.67078","volume":"30","author":"OA Abulkhair","year":"2010","unstructured":"Abulkhair, O. A. et al. The first national public breast cancer screening program in Saudi Arabia. Ann. Saudi Med. 30(5), 350\u2013357 (2010).","journal-title":"Ann. Saudi Med."},{"issue":"10","key":"4374_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.26719\/2010.16.10.1025","volume":"16","author":"SS Akhtar","year":"2010","unstructured":"Akhtar, S. S. et al. First organized screening mammography programme in Saudi Arabia: preliminary analysis of pilot round. East Mediterr. Health J. 16(10), 1025\u20131031 (2010).","journal-title":"East Mediterr. Health J."},{"issue":"5","key":"4374_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jiph.2019.06.001","volume":"12","author":"IM Gosadi","year":"2019","unstructured":"Gosadi, I. M. National screening programs in Saudi Arabia: Overview, outcomes, and effectiveness. J. Infect. Public Health 12(5), 608\u2013614 (2019).","journal-title":"J. Infect. Public Health"},{"issue":"5","key":"4374_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.rbmo.2013.01.007","volume":"26","author":"N Gleicher","year":"2013","unstructured":"Gleicher, N. Why are reproductive cancers more common in nulliparous women?. Reprod. Biomed. Online 26(5), 416\u2013419 (2013).","journal-title":"Reprod. Biomed. Online"},{"key":"4374_CR12","unstructured":"American Cancer Society. Endometrial cancer 2021 26 January 2021 [cited 2021 9 july 2021]; Available from: https:\/\/www.cancer.org\/cancer\/endometrial-cancer\/detection-diagnosis-staging\/survival-rates.html."},{"key":"4374_CR13","unstructured":"Cancer Research UK Cancer Statistics 2021 [cited 2021 9 july 2021]; Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/uterine-cancer\/survival#heading-One."},{"key":"4374_CR14","unstructured":"Cancer Stat Facts: Bladder Cancer. 2021 [cited 2021 31 January 2021]; Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html."},{"issue":"1","key":"4374_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/jamaoncol.2014.161","volume":"1","author":"C Zeng","year":"2015","unstructured":"Zeng, C. et al. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncol. 1(1), 88\u201396 (2015).","journal-title":"JAMA Oncol."},{"issue":"12","key":"4374_CR16","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.31557\/APJCP.2018.19.12.3401","volume":"19","author":"A Khoja","year":"2018","unstructured":"Khoja, A. et al. Utilization of Colorectal Cancer Screening among Saudi Elderly Population: A Study from the Saudi National Survey for Elderly Health. Asian Pac. J. Cancer Prev. 19(12), 3401\u20133407 (2018).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"4374_CR17","unstructured":"Cancer Reaserch UK. Prostate Cancer Incidence Statistics 2021 [cited 2021 31 January 2021]; Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/prostate-cancer\/incidence#heading-Zero."},{"key":"4374_CR18","unstructured":"Cancer Stat Facts: Prostate Cancer. 2020 [cited 2021 31 January 2021]; Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html."},{"issue":"6","key":"4374_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.5306\/wjco.v8.i6.447","volume":"8","author":"MA Arafa","year":"2017","unstructured":"Arafa, M. A. & Rabah, D. M. With increasing trends of prostate cancer in the Saudi Arabia and Arab World: Should we start screening programs?. World J. Clin. Oncol. 8(6), 447\u2013449 (2017).","journal-title":"World J. Clin. Oncol."},{"issue":"6","key":"4374_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1440-1746.2003.03334.x","volume":"19","author":"EA Ayoola","year":"2004","unstructured":"Ayoola, E. A. & Gadour, M. O. Hepatocellular carcinoma in Saudi Arabia: Role of hepatitis B and C infection. J. Gastroenterol. Hepatol. 19(6), 665\u2013669 (2004).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"4374_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/lv.2000.4875","volume":"6","author":"LL Wong","year":"2000","unstructured":"Wong, L. L. et al. Improved survival with screening for hepatocellular carcinoma. Liver Transpl. 6(3), 320\u2013325 (2000).","journal-title":"Liver Transpl."},{"key":"4374_CR22","unstructured":"National Health Information Center. Cancer Incidence Report, Saudi Arabia, 2012 [cited 2021 9 July 2021]; Available from: https:\/\/nhic.gov.sa\/en\/eServices\/Pages\/TumorRegistration.aspx."},{"issue":"5","key":"4374_CR23","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng, H. et al. Changing cancer survival in China during 2003\u201315: a pooled analysis of 17 population-based cancer registries. Lancet Glob. Health 6(5), e555\u2013e567 (2018).","journal-title":"Lancet Glob. Health"},{"issue":"11","key":"4374_CR24","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","volume":"20","author":"M Arnold","year":"2019","unstructured":"Arnold, M. et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 20(11), 1493\u20131505 (2019).","journal-title":"Lancet Oncol."},{"issue":"1","key":"4374_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejca.2006.07.021","volume":"43","author":"N Bossard","year":"2007","unstructured":"Bossard, N. et al. Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur. J. Cancer 43(1), 149\u2013160 (2007).","journal-title":"Eur. J. Cancer"},{"key":"4374_CR26","unstructured":"Ministry of Health acheivments 2013 [cited 2021 5 July 2021]; Ministry of Health acheivments report 2013]. Available from: https:\/\/www.moh.gov.sa\/en\/Documents\/Facts."},{"issue":"10125","key":"4374_CR27","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani, C. et al. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391(10125), 1023\u20131075 (2018).","journal-title":"Lancet"},{"issue":"12","key":"4374_CR28","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.15537\/smj.2018.12.23348","volume":"39","author":"MA Althubiti","year":"2018","unstructured":"Althubiti, M. A. & Nour Eldein, M. M. Trends in the incidence and mortality of cancer in Saudi Arabia. Saudi Med. J. 39(12), 1259\u20131262 (2018).","journal-title":"Saudi Med. J."},{"issue":"15","key":"4374_CR29","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.ejca.2015.08.001","volume":"51","author":"S Rossi","year":"2015","unstructured":"Rossi, S. et al. The EUROCARE-5 study on cancer survival in Europe 1999\u20132007: Database, quality checks and statistical analysis methods. Eur. J. Cancer 51(15), 2104\u20132119 (2015).","journal-title":"Eur. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04374-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:08:24Z","timestamp":1669320504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-04374-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4374"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-04374-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]},"assertion":[{"value":"23 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}